Latest news
Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:54:41 GMTCollegium Pharmaceutical Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 17:31:22 GMTCollegium Pharmaceutical Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 13:04:01 GMTCollegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 12:28:00 GMTCollegium Q2 revenue rises 6 percent to $199.9 million - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:45:00 GMTInflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:40:35 GMTWinshear Reports Drill Results from the Rodburn Target, Portsoy Project, NE Scotland - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:40:33 GMTCollegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:30:00 GMT